NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Nautilus Biotechnology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$2.63+0.57 (+27.67%)
Close on Oct 19, 2026
- Market cap
- $334.37M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
39.4%
50M of 127M shares
Institutional holders
93
30 new, 17 sold out
Net institutional buying
-4M
In Q2 2026
Insider trades, 12 months
2 buys · 2 sales
Net sold $11.68M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Marc L. Andreessen | 9,063,054 | 7.10% | 13D (active) amendment | Jun 26, 2026 |
| Parag Mallick | 22,557,411 | 17.60% | 13D (active) amendment | Mar 2, 2026 |
| Sujal Patel | 21,249,965 | 16.30% | 13D (active) amendment | Mar 2, 2026 |
| Joseph Edelman | 11,634,211 | 9.10% | 13D (active) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NAUT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 11,634,211 | 9.14% | $21.76M | −960,000 | 0.33% |
| a16z Capital Management, L.L.C. | 9,063,054 | 7.12% | $16.95M | −8,590,863 | 0.12% |
| Cercano Management LLC | 7,172,985 | 5.64% | $13.41M | – | 1.79% |
| BlackRock, Inc. | 2,687,226 | 2.11% | $5.03M | +2,499,555 | 0.00% |
| Vanguard Capital Management LLC | 2,549,979 | 2.00% | $4.77M | +4,382 | 0.00% |
| Comprehensive Financial Management LLC | 2,207,619 | 1.73% | $4.13M | – | 0.14% |
| Citadel Advisors LLC | 1,896,192 | 1.49% | $3.55M | New | 0.00% |
| Geode Capital Management, LLC | 1,265,535 | 0.99% | $2.37M | +662,011 | 0.00% |
| Acadian Asset Management LLC | 1,055,461 | 0.83% | $1.97K | +314,215 | 0.00% |
| Clearstead Advisors, LLC | 892,787 | 0.70% | $1.67M | −1,436,997 | 0.02% |
| Susquehanna International Group, Llp | 890,949 | 0.70% | $1.67M | New | 0.00% |
| Sentinel Trust Co Lba | 750,000 | 0.59% | $1.40K | – | 0.12% |
| Barclays PLC | 725,321 | 0.57% | $1.36M | +651,996 | 0.00% |
| Renaissance Technologies LLC | 690,514 | 0.54% | $1.29M | +424,814 | 0.00% |
| JPMorgan Chase & Co | 614,177 | 0.48% | $1.10M | New | 0.00% |
| State Street Corp | 559,508 | 0.44% | $1.05M | +343,238 | 0.00% |
| Dimensional Fund Advisors LP | 475,844 | 0.37% | $889.25K | +146,721 | 0.00% |
| Northern Trust Corp | 381,234 | 0.30% | $712.91K | +274,223 | 0.00% |
| Hrt Financial LP | 361,073 | 0.28% | $675 | +295,819 | 0.00% |
| Vanguard Fiduciary Trust Co | 353,093 | 0.28% | $660.28K | +47,567 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 93 | 50M | 39.4% | 30 / 29 | 12 / 17 | 11M | 15M |
| Q1 2026 | 81 | 54M | 42.7% | 25 / 16 | 17 / 9 | 7M | 1M |
| Q4 2025 | 68 | 58M | 45.9% | 11 / 19 | 14 / 7 | 2M | 2M |
| Q3 2025 | 68 | 58M | 45.5% | 9 / 9 | 28 / 12 | 1M | 3M |
| Q2 2025 | 71 | 60M | 47.0% | 12 / 25 | 17 / 28 | 4M | 7M |
| Q1 2025 | 88 | 63M | 49.3% | 14 / 19 | 30 / 12 | 1M | 2M |
| Q4 2024 | 88 | 64M | 50.2% | 16 / 26 | 17 / 11 | 1M | 1M |
| Q3 2024 | 83 | 64M | 50.5% | 9 / 23 | 12 / 2 | 4M | 0M |
| Q2 2024 | 77 | 64M | 50.3% | 8 / 23 | 20 / 4 | 1M | 1M |
| Q1 2024 | 73 | 64M | 50.4% | 5 / 18 | 24 / 8 | 1M | 1M |
| Q4 2023 | 76 | 64M | 50.2% | 8 / 26 | 22 / 6 | 22M | 2M |
| Q3 2023 | 75 | 45M | 35.4% | 5 / 25 | 12 / 5 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of NAUT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,930,610 | 1.52% | $3.61M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,072,858 | 0.84% | $2.01M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 543,262 | 0.43% | $1.02M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 541,671 | 0.43% | $529.21K | 0.00% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 387,428 | 0.30% | $724.49K | 0.00% | Jun 30, 2026 |
| JPMorgan Small Cap Value Fund | 332,886 | 0.26% | $622.50K | 0.05% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 250,996 | 0.20% | $687.73K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 166,544 | 0.13% | $311.44K | 0.02% | Jun 30, 2026 |
| Ultra-Small Company Market Fund | 130,000 | 0.10% | $243.10K | 0.16% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 121,119 | 0.10% | $118.33K | 0.00% | Jul 31, 2026 |
| U.S. Small Cap Portfolio | 108,163 | 0.08% | $105.68K | 0.00% | Jul 31, 2026 |
| U.S. Small Cap Equity Fund | 100,386 | 0.08% | $98.08K | 0.01% | Jul 31, 2026 |
| Master Small Cap Index Series | 92,957 | 0.07% | $173.83K | 0.00% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 91,529 | 0.07% | $250.79K | 0.00% | May 31, 2026 |
| Dimensional U.S. Small Cap ETF | 84,337 | 0.07% | $82.40K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Sujal M. Patel | CEO, President, and Secretary, Director, 10% owner | 17,461,232 | 13.72% | Mar 4, 2026 |
| Parag Mallick | Chief Scientist, Director, 10% owner | 20,493,392 | 16.10% | Mar 4, 2026 |
| Subramanian Sankar | Senior VP, Product Development | 91,250 | 0.07% | Mar 4, 2026 |
| Gwen E. Weld | Chief People Officer | 30,000 | 0.02% | Mar 4, 2026 |
| Kentaro Suzuki | Chief Marketing Officer | 4,000 | 0.00% | Mar 4, 2026 |
| Anna Mowry | CFO and Treasurer | 83,000 | 0.07% | Mar 4, 2026 |
| Matthew B. Murphy | General Counsel | 75,390 | 0.06% | Mar 4, 2026 |
| Nicholas A. Nelson | CBO & Senior VP, Bus. Dev. | – | – | Mar 4, 2025 |
| Matthew S. McIlwain | Director | 6,479,845 | 5.09% | Jun 22, 2026 |
| Karen Akinsanya | Director | – | – | Jun 22, 2026 |
| Farzad Nazem | Director | 1,888,146 | 1.48% | Jun 22, 2026 |
| Epperly Melissa B, | Director | – | – | Jun 22, 2026 |
| Matthew L. Posard | Director | 140,000 | 0.11% | Jun 22, 2026 |
| Andreessen Horowitz LSV Fund II, L.P. | 10% owner | – | – | Jun 4, 2026 |
| AH Bio Fund II, L.P. | 10% owner | 12,653,917 | 9.94% | Jun 4, 2026 |
| Marc L. Andreessen | 10% owner | – | – | Jun 4, 2026 |
| Benjamin A. Horowitz | 10% owner | – | – | Jun 4, 2026 |
| AH Equity Partners LSV II, L.L.C. | 10% owner | – | – | Jun 4, 2026 |
| AH Equity Partners Bio II, L.L.C. | 10% owner | 17,653,917 | 13.87% | Jun 4, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| AH Bio Fund II, L.P. 10% owner | Jun 2, 2026 | Sale | −384,026 | $2.35 | $902.46K | 971,885 |
| AH Bio Fund II, L.P. 10% owner | Jun 2, 2026 | Sale | −4,615,974 | $2.35 | $10.85M | 11,682,032 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Mar 4, 2026 | Buy | +25,000 | $2.61 | $65.25K | 10,366,721 |
| Kentaro Suzuki Chief Marketing Officer | Nov 6, 2025 | Buy | +4,000 | $1.49 | $5.96K | 4,000 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Sep 8, 2025 | Buy | +83,500 | $0.68 | $56.78K | 10,341,721 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Sep 5, 2025 | Buy | +116,500 | $0.67 | $78.06K | 10,258,221 |
| Matthew B. Murphy General Counsel | Sep 4, 2025 | Buy | +20,000 | $0.64 | $12.80K | 74,140 |
| Anna Mowry CFO and Treasurer | May 29, 2025 | Buy | +15,000 | $0.77 | $11.55K | 83,000 |
| Parag Mallick Chief Scientist, Director, 10% owner | May 12, 2025 | Buy | +1,500 | $0.73 | $1.10K | 20,493,392 |
| Parag Mallick Chief Scientist, Director, 10% owner | May 8, 2025 | Buy | +12,000 | $0.73 | $8.76K | 20,491,892 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Mar 20, 2025 | Buy | +23,933 | $1.00 | $23.93K | 10,141,721 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Mar 19, 2025 | Buy | +53,300 | $0.99 | $52.77K | 10,117,788 |
| Mary E. Godwin Senior VP, Operations | Sep 23, 2024 | Sale | −47,031 | $2.87 | $134.98K | 0 |
| Mary E. Godwin Senior VP, Operations | Sep 23, 2024 | Option exercise | +47,031 | $0.46 | $21.63K | 47,031 |
| Mary E. Godwin Senior VP, Operations | Sep 17, 2024 | Option exercise | +35,000 | $0.46 | $16.10K | 35,000 |
| Mary E. Godwin Senior VP, Operations | Sep 17, 2024 | Sale | −35,000 | $2.85 | $99.75K | 0 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Mar 11, 2024 | Buy | +12,044 | $2.84 | $34.20K | 10,064,488 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Mar 8, 2024 | Buy | +2,430 | $2.99 | $7.27K | 10,052,444 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Mar 7, 2024 | Buy | +18,854 | $2.89 | $54.49K | 10,050,014 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Mar 6, 2024 | Buy | +9,267 | $2.70 | $25.02K | 10,031,160 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Mar 5, 2024 | Buy | +7,405 | $2.65 | $19.62K | 10,021,893 |
| Subramanian Sankar Senior VP, Product Development | Sep 27, 2022 | Buy | +5,000 | $2.03 | $10.15K | 91,250 |
| Subramanian Sankar Senior VP, Product Development | Sep 26, 2022 | Buy | +10,000 | $2.03 | $20.30K | 86,250 |
| Gwen E. Weld Chief People Officer | Sep 23, 2022 | Buy | +30,000 | $2.03 | $60.90K | 30,000 |
| Subramanian Sankar Senior VP, Product Development | Sep 16, 2022 | Buy | +35,000 | $2.16 | $75.60K | 75,000 |
| Subramanian Sankar Senior VP, Product Development | Sep 15, 2022 | Buy | +40,000 | $2.19 | $87.60K | 40,000 |
| Anna Mowry CFO and Treasurer | Aug 19, 2022 | Buy | +17,500 | $2.30 | $40.25K | 56,750 |
| Matthew B. Murphy General Counsel | Aug 15, 2022 | Buy | +7,500 | $2.84 | $21.30K | 54,140 |
| Matthew B. Murphy General Counsel | Aug 12, 2022 | Buy | +2,500 | $2.85 | $7.13K | 46,640 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Aug 8, 2022 | Buy | +8,346 | $2.93 | $24.45K | 10,014,488 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Aug 5, 2022 | Buy | +41,654 | $2.92 | $121.63K | 10,006,142 |
| Anna Mowry CFO and Treasurer | Jun 27, 2022 | Buy | +5,500 | $2.75 | $15.13K | 39,250 |
| Matthew B. Murphy General Counsel | May 12, 2022 | Award | +10,000 | $3.28 | $32.80K | 44,140 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | May 9, 2022 | Buy | +50,000 | $3.96 | $198.00K | 9,964,488 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Mar 4, 2022 | Option exercise | +100 | $10.00 | $1.00K | 9,914,488 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Mar 3, 2022 | Buy | +50,000 | $3.60 | $180.00K | 9,914,388 |
| Parag Mallick Chief Scientist, Director, 10% owner | Dec 21, 2021 | Gift | −210,000 | – | – | 20,479,892 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Dec 8, 2021 | Buy | +200,000 | $5.36 | $1.07M | 9,111,151 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Dec 1, 2021 | Buy | +88,022 | $4.73 | $416.34K | 9,864,388 |
| Matthew L. Posard Director | Dec 1, 2021 | Buy | +10,000 | $4.46 | $44.60K | 40,000 |
| Matthew L. Posard Director | Dec 1, 2021 | Buy | +10,000 | $4.45 | $44.50K | 50,000 |
| Matthew L. Posard Director | Dec 1, 2021 | Buy | +10,000 | $4.50 | $45.00K | 30,000 |
| Sujal M. Patel CEO, President, and Secretary, Director, 10% owner | Nov 30, 2021 | Buy | +161,978 | $4.72 | $764.54K | 9,776,366 |
| Matthew L. Posard Director | Nov 30, 2021 | Buy | +20,000 | $4.57 | $91.40K | 20,000 |
| Anna Mowry CFO and Treasurer | Nov 24, 2021 | Buy | +15,000 | $4.58 | $68.70K | 32,500 |
| Matthew S. McIlwain Director | Nov 15, 2021 | Buy | +100,000 | $5.30 | $530.00K | 459,075 |
| Matthew S. McIlwain Director | Aug 26, 2021 | Buy | +11,709 | $7.71 | $90.28K | 359,075 |
| Matthew S. McIlwain Director | Aug 25, 2021 | Buy | +11,693 | $7.74 | $90.50K | 347,366 |
| Matthew S. McIlwain Director | Aug 24, 2021 | Buy | +13,568 | $7.68 | $104.20K | 335,673 |
| Matthew B. Murphy General Counsel | Aug 13, 2021 | Buy | +5,000 | $7.56 | $37.80K | 34,140 |
| Anna Mowry CFO and Treasurer | Aug 12, 2021 | Buy | +17,500 | $7.71 | $134.93K | 17,500 |
| Life Sciences Master Fund Ltd Perceptive – | Jun 9, 2021 | Buy | +5,500,000 | $10.00 | $55.00M | 5,997,038 |
| Life Sciences Master Fund Ltd Perceptive – | Jun 9, 2021 | Other | +2,914,113 | – | – | 8,911,151 |
| Michael Seth Altman Director | Jun 9, 2021 | Conversion | +499,000 | – | – | 499,000 |
| Michael Seth Altman Director | Jun 9, 2021 | Conversion | +3,647,500 | – | – | 3,647,500 |
| Michael Seth Altman Director | Jun 9, 2021 | Conversion | −499,000 | – | – | 0 |
| Advisors Llc Perceptive Director | Jun 3, 2021 | Buy | +330,050 | $10.05 | $3.32M | 489,975 |
| Life Sciences Master Fund Ltd Perceptive – | May 24, 2021 | Buy | +7,063 | $10.05 | $70.98K | 497,038 |
| Life Sciences Master Fund Ltd Perceptive Director | May 20, 2021 | Buy | +159,925 | $10.05 | $1.61M | 159,925 |
| Sciences Holdings ARYA III 10% owner | Aug 11, 2020 | Other | +499,000 | $10.00 | $4.99M | 499,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Godwin Mary Officer | Dec 17, 2024 | 38,337 | $74.26K | Dec 17, 2024 | Stock Option Exercise |
| Godwin Mary Officer | Dec 9, 2024 | 35,000 | $74.59K | Dec 9, 2024 | Stock Option Exercise |
| Godwin Mary Officer | Dec 3, 2024 | 60,000 | $131.78K | Dec 3, 2024 | Stock Option Exercise |
| Godwin Mary Officer | Nov 26, 2024 | 60,000 | $136.51K | Nov 26, 2024 | Stock Option Exercise |
| Godwin Mary Officer | Nov 21, 2024 | 30,000 | $70.62K | Nov 21, 2024 | Stock Option Exercise |
| Godwin Mary Officer | Nov 19, 2024 | 30,000 | $68.05K | Nov 19, 2024 | Stock Option Exercise |
| Godwin Mary Officer | Nov 12, 2024 | 40,000 | $98.88K | Nov 11, 2024 | Stock Option Exercise |
| Elizabeth Godwin Mary Officer | Nov 8, 2024 | 31,078 | $78.16K | Nov 8, 2024 | Stock Option Exercise |
| Elizabeth Godwin Mary Officer | Nov 7, 2024 | 28,922 | $79.64K | Nov 7, 2024 | Stock Option Exercise |
| Elizabeth Godwin Mary Officer | Sep 23, 2024 | 47,031 | $134.74K | Sep 23, 2024 | Stock Option Exercise |
| Elizabeth Godwin Mary Officer | Sep 17, 2024 | 35,000 | $99.87K | Sep 17, 2024 | Stock Option Exercise |